{"content":"<li class=\"n-box-item date-title\" data-end=\"1486443599\" data-start=\"1486357200\" data-txt=\"Sunday, December 22, 2019\">Monday, February  6, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3240955\" data-ts=\"1486427155\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHTR\" target=\"_blank\">CHTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240955-charter-closes-sale-of-1b-in-10-year-notes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Charter closes sale of $1B in 10-year notes</a></h4><ul>   <li>Charter Communications (<a href='https://seekingalpha.com/symbol/CHTR' title='Charter Communications, Inc.'>CHTR</a> <font color='red'>-1.9%</font>) today <a href=\"https://seekingalpha.com/pr/16733713-charter-closes-1_0-billion-senior-unsecured-notes\" target=\"_blank\">closed on its sale</a> of $1B in debt.</li>    <li>The company issued the notes at par through subsidiaries CCO Holdings and CCO Holdings Capital.</li>    <li>The debt is in senior unsecured notes due 2027 and bearing interest of 5.125% annually.</li>    <li>At last report, Charter noted total long-term debt of $59.95B, and cash and equivalents of $1.17B.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3240955\" data-linked=\"Charter closes sale of $1B in 10-year notes\" data-tweet=\"$CHTR - Charter closes sale of $1B in 10-year notes https://seekingalpha.com/news/3240955-charter-closes-sale-of-1b-in-10-year-notes?source=tweet\" data-url=\"https://seekingalpha.com/news/3240955-charter-closes-sale-of-1b-in-10-year-notes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240953\" data-ts=\"1486427040\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FMC\" target=\"_blank\">FMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240953-fmcminus-4_3-after-guiding-q1-earnings-well-below-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FMC -4.3% after guiding Q1 earnings well below estimates</a></h4><ul>     <li>FMC&nbsp;Corp. (NYSE:<a href='https://seekingalpha.com/symbol/FMC' title='FMC Corporation'>FMC</a>) <font color='red'>-4.3%</font>&nbsp;AH after reporting slightly weaker than expected <a href=\"https://seekingalpha.com/news/3240905-fmc-misses-0_01-misses-revenue\" target=\"_blank\">Q4 earnings</a> and revenues, and issuing below consensus Q1 earnings.</li><li>FMC says Q4 agricultural segment earnings rose 25% Y/Y to $127M, health and nutrition earnings gained 17% to $54M, and lithium earnings jumped more than 90% to $21M.</li><li>For FY 2017, FMC sees EPS of $3.20-$3.60, in-line with the $3.31 analyst consensus estimate, but for Q1 it expects EPS of just $0.50-$0.60, vs. $0.74 consensus, as ag segment earnings are forecast at $60M-$70M, a  ~20% Y/Y decrease at the mid-point.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3240953\" data-linked=\"FMC -4.3% after guiding Q1 earnings well below estimates\" data-tweet=\"$FMC - FMC -4.3% after guiding Q1 earnings well below estimates https://seekingalpha.com/news/3240953-fmcminus-4_3-after-guiding-q1-earnings-well-below-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3240953-fmcminus-4_3-after-guiding-q1-earnings-well-below-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240952\" data-ts=\"1486426623\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCOR\" target=\"_blank\">SCOR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240952-comscore-confirms-delisting-coming-wednesday-morning\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ComScore confirms delisting coming Wednesday morning</a></h4><ul>   <li>ComScore (NASDAQ:<a href='https://seekingalpha.com/symbol/SCOR' title='comScore, Inc.'>SCOR</a>) has confirmed it's heard from Nasdaq, which intends to delist the stock and suspend trading <a href=\"https://seekingalpha.com/pr/16734212-comscore-announces-anticipated-delisting-nasdaq-effective-february-8-2017\" target=\"_blank\">effective with Wednesday's market open</a>.</li>    <li>That's after comScore informed the exchange's Hearings Panel that it <a href=\"https://seekingalpha.com/news/3240775-set-miss-new-compliance-deadline-comscore-tumbles-21_9-percent\" target=\"_blank\">wasn't going to meet a Feb. 23 deadline</a> to regain compliance with financial reporting requirements.</li>    <li>Shares have stabilized some after hours, <font color='green'>up 0.8%</font>, after <font color='red'>sliding 28.4%</font> during market hours.</li>    <li>ComScore has appealed the decision, but can't give assurance that it will be stayed before Wednesday.</li>    <li>Earlier, Oppenheimer <a href=\"https://seekingalpha.com/news/3240855-comscore-now-28_9-percent-oppenheimer-pulls-buy-rating\" target=\"_blank\">pulled its Buy rating</a> and $35 price target in anticipation of a likely delisting, though it thinks the firm could still draw a buyer from suitors like Adobe, Oracle or IBM.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3240952\" data-linked=\"ComScore confirms delisting coming Wednesday morning\" data-tweet=\"$SCOR - ComScore confirms delisting coming Wednesday morning https://seekingalpha.com/news/3240952-comscore-confirms-delisting-coming-wednesday-morning?source=tweet\" data-url=\"https://seekingalpha.com/news/3240952-comscore-confirms-delisting-coming-wednesday-morning\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240946\" data-ts=\"1486424009\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OXY\" target=\"_blank\">OXY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240946-occidental-petroleum-says-replaced-nearly-190-of-2016-production\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Occidental Petroleum says it replaced nearly 190% of 2016 production</a></h4><ul>     <li>Occidental Petroleum (NYSE:<a href='https://seekingalpha.com/symbol/OXY' title='Occidental Petroleum Corporation'>OXY</a>)&nbsp;<font color='green'>+2.7%</font>&nbsp;AH after reporting a nearly <a href=\"https://seekingalpha.com/pr/16734001-occidental-petroleum-replaces-nearly-190-percent-2016-production\" target=\"_blank\">190% replacement ratio</a>, including 290% resources replacement in the Permian Basin.</li>     <li>OXY says its preliminary worldwide proved reserves at year-end 2016 rose to 2.4B boe from 2.2B boe at the end of 2015, and had proved reserve additions from all sources of 437M boe from production of 231M boe in 2016.</li>     <li>OXY says its 2016 reserves program additions for Permian resources came in at historically low finding and development costs of less than $9/boe.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3240946\" data-linked=\"Occidental Petroleum says it replaced nearly 190% of 2016 production\" data-tweet=\"$OXY - Occidental Petroleum says it replaced nearly 190% of 2016 production https://seekingalpha.com/news/3240946-occidental-petroleum-says-replaced-nearly-190-of-2016-production?source=tweet\" data-url=\"https://seekingalpha.com/news/3240946-occidental-petroleum-says-replaced-nearly-190-of-2016-production\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240944\" data-ts=\"1486423471\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LMNX\" target=\"_blank\">LMNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240944-luminex-q4-revenues-up-20-earnings-down-117-cash-flow-ops-up-3-shares-down-2-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Luminex Q4 revenues up 20%; earnings down 117%; cash flow ops up 3%; shares down 2% after hours</a></h4><ul><li>Luminex (NASDAQ:<a href='https://seekingalpha.com/symbol/LMNX' title='Luminex Corporation'>LMNX</a>) <a href=\"https://seekingalpha.com/pr/16734005-luminex-corporation-reports-fourth-quarter-full-year-2016-results\" target=\"_blank\">Q4 results</a> ($M): Total Revenues: 72.3 (+19.7%); Assays: 36.7 (+36.4%).</li><li>Net Income: (3.4) (-116.7%); Non-GAAP Net Income: 4.6 (-80.9%); EPS: (0.08) (-116.7%); Non-GAAP EPS: 0.11 (-80.7%); CF Ops: 13.9 (+3.4%).</li><li><strong>2017 Guidance</strong>: Revenues: $295M - 305M.</li><li><strong>Q1 Guidance</strong>: Revenues: $73M - 75M.</li><li>Shares are off&nbsp;<font color='red'>2%</font>&nbsp;after hours on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3240944\" data-linked=\"Luminex Q4 revenues up 20%; earnings down 117%; cash flow ops up 3%; shares down 2% after hours\" data-tweet=\"$LMNX - Luminex Q4 revenues up 20%; earnings down 117%; cash flow ops up 3%; shares down 2% after hours https://seekingalpha.com/news/3240944-luminex-q4-revenues-up-20-earnings-down-117-cash-flow-ops-up-3-shares-down-2-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3240944-luminex-q4-revenues-up-20-earnings-down-117-cash-flow-ops-up-3-shares-down-2-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:24 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240942\" data-ts=\"1486422872\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AUPH\" target=\"_blank\">AUPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240942-new-chief-aurinia-shares-down-9\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New chief at Aurinia; shares down 9%</a></h4><ul><li>Aurinia Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/AUPH' title='Aurinia Pharmaceuticals Inc.'>AUPH</a>) <a href=\"https://seekingalpha.com/pr/16734156-aurinia-announces-appointment-company-founder-dr-richard-m-glickman-new-chief-executive\" target=\"_blank\">appoints </a>founder and Chairman Dr. Richard Glickman as Chairman and CEO replacing Charles Rowland who resigned. His primary goal is to advance lupus nephritis candidate voclosporin through Phase 3 development and ultimately into the marketplace.</li><li>Shares are off&nbsp;<font color='red'>9%</font>&nbsp;after hours on increased volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3240942\" data-linked=\"New chief at Aurinia; shares down 9%\" data-tweet=\"$AUPH - New chief at Aurinia; shares down 9% https://seekingalpha.com/news/3240942-new-chief-aurinia-shares-down-9?source=tweet\" data-url=\"https://seekingalpha.com/news/3240942-new-chief-aurinia-shares-down-9\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240935\" data-ts=\"1486421317\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPS\" target=\"_blank\">GPS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240935-gap-sees-above-consensus-q4-results-after-strong-holiday-quarter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gap sees above consensus Q4 results after strong holiday quarter</a></h4><ul>     <li>Gap (NYSE:<a href='https://seekingalpha.com/symbol/GPS' title='The Gap, Inc.'>GPS</a>)&nbsp;<font color='green'>+3.1%</font>&nbsp;AH after reporting <a href=\"https://seekingalpha.com/pr/16734050-gap-inc-reports-january-fourth-quarter-results\" target=\"_blank\">stronger than expected Q4 sales</a>,  which rose 1% Y/Y to $4.43B and beat the analyst consensus estimate of $4.39B, and net sales for January rose 2% to $828M.</li>     <li>Gap says sales at stores open for at least a year improved 2%, as Old Navy and Gap sales offset a 3% decline at Banana Republic.</li>          <li>Gap also says it expects Q4 adjusted EPS of $0.51-$0.50 vs. analyst expectations for $0.45; for the full year, Gap expects adjusted EPS of $2.01-$2.02 vs. its earlier view of $1.87-$1.92.</li></ul><div class=\"tiny-share-widget\" data-id=\"3240935\" data-linked=\"Gap sees above consensus Q4 results after strong holiday quarter\" data-tweet=\"$GPS - Gap sees above consensus Q4 results after strong holiday quarter https://seekingalpha.com/news/3240935-gap-sees-above-consensus-q4-results-after-strong-holiday-quarter?source=tweet\" data-url=\"https://seekingalpha.com/news/3240935-gap-sees-above-consensus-q4-results-after-strong-holiday-quarter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240932\" data-ts=\"1486420590\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240932-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/MFIN' title='Medallion Financial'>MFIN</a> <font color='green'>+7.1%</font>. <a href='https://seekingalpha.com/symbol/ALSN' title='Allison Transmission'>ALSN</a> <font color='green'>+5.4%</font>. <a href='https://seekingalpha.com/symbol/GPS' title='The Gap, Inc.'>GPS</a> <font color='green'>+3.1%</font>. <a href='https://seekingalpha.com/symbol/FN' title='Fabrinet'>FN</a> <font color='green'>+3.3%</font>. <a href='https://seekingalpha.com/symbol/NM' title='Navios Maritime Holdings Inc.'>NM</a> <font color='green'>+2.0%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/HQY' title='HealthEquity'>HQY</a> <font color='red'>-5.3%</font>. <a href='https://seekingalpha.com/symbol/KN' title='Knowles Corporation'>KN</a> <font color='red'>-4.3%</font>. <a href='https://seekingalpha.com/symbol/AM' title='Antero Midstream Partners'>AM</a> <font color='red'>-3.4%</font>. <a href='https://seekingalpha.com/symbol/CEMP' title='Cempra, Inc.'>CEMP</a> <font color='red'>-3.2%</font>. <a href='https://seekingalpha.com/symbol/YRCW' title='YRC Worldwide, Inc.'>YRCW</a> <font color='red'>-2.2%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3240932\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$MFIN $ALSN $GPS - After Hours Gainers / Losers https://seekingalpha.com/news/3240932-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3240932-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240919\" data-ts=\"1486418427\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FN\" target=\"_blank\">FN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240919-fabrinetplus-2_85-q2-2017-outlook-positive\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fabrinet +2.85%; Q2 2017, outlook positive</a></h4><ul><li><strong><a href=\"https://seekingalpha.com/news/3240888-fabrinet-beats-0_12-beats-revenue\" target=\"_blank\">Q2 2017 results</a></strong> &ndash; revenue $351.2M (+50.7% Y/Y,&nbsp;<font color='green'>$16.13M above estimates</font>), EPS $0.91 (<font color='green'>$0.12 above estimates</font>), net income $34.5M (+89% Y/Y)</li><li><strong>Q3 2017 projections</strong> &ndash; revenue $360M-$364M (<a href=\"https://finance.yahoo.com/quote/FN/analysts?p=FN\" target=\"_blank\">consensus $334.79</a>), EPS $0.87-$0.89 (consensus $0.78)</li><li><strong>Other developments</strong>&nbsp;&ndash; CEO succession plan, with no set timeframe, initiated.</li><li>Fabrinet (NYSE:<a href='https://seekingalpha.com/symbol/FN' title='Fabrinet'>FN</a>) CEO Tom Mitchell: \"We exceeded our guidance for the second quarter, with revenue that grew 51% from a year ago. We are enthusiastic about our continued business momentum, driven by on-going strength in the optical market and new customer programs. We&rsquo;re also excited to see the beginning of the transfer of programs from our new product introduction facility in Santa Clara to&nbsp;Thailand, and believe our growing NPI pipeline will support our growth in the years ahead.\"</li><li><strong>After hours</strong> &ndash; Fabrinet $43.30</li><li><a href=\"http://edge.media-server.com/m/p/4jd74ewq\" target=\"_blank\">Conference call</a></li><li><a href=\"https://seekingalpha.com/pr/16734056-fabrinet-announces-second-quarter-fiscal-year-2017-financial-results\" target=\"_blank\">Press release</a></li><li><a href=\"http://files.shareholder.com/downloads/AMDA-QYMFK/3820333723x0x859001/1CA0BCCE-D455-4C9D-B5BE-4E572DD1E29D/Fabrinet_Investor_Presentation_FQ217.pdf\" target=\"_blank\">Presentation</a></li><li><a href=\"https://seekingalpha.com/filing/3387550\" target=\"_blank\">8-K</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3240919\" data-linked=\"Fabrinet +2.85%; Q2 2017, outlook positive\" data-tweet=\"$FN - Fabrinet +2.85%; Q2 2017, outlook positive https://seekingalpha.com/news/3240919-fabrinetplus-2_85-q2-2017-outlook-positive?source=tweet\" data-url=\"https://seekingalpha.com/news/3240919-fabrinetplus-2_85-q2-2017-outlook-positive\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240912\" data-ts=\"1486417467\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLLS\" target=\"_blank\">CLLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240912-cellectis-gets-green-light-to-start-clinical-trials-in-u-s-ucart123-shares-ahead-9-after\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cellectis gets green light to start clinical trials in U.S. with UCART123; shares ahead 9% after hours</a></h4><ul><li>Thinly traded Cellectis (NASDAQ:<a href='https://seekingalpha.com/symbol/CLLS' title='Cellectis S.A.'>CLLS</a>) is up&nbsp;<font color='green'>9%</font>&nbsp;after hours on light volume in response to its <a href=\"https://seekingalpha.com/pr/16734101-fda-grants-cellectis-ind-approval-proceed-clinical-development-ucart123-first-gene-edited\" target=\"_blank\">announcement </a>that the FDA has approved its IND for off-the-shelf CAR T candidate UCART123. The company plans to initiate Phase 1 studies in H1.</li><li><a href=\"http://www.cellectis.com/en/content/ucarts\" target=\"_blank\">UCART123</a>&nbsp;is&nbsp;an&nbsp;<a href=\"http://www.cellectis.com/en/engineered-t-cells\" target=\"_blank\">engineered T-cell therapy</a>&nbsp;candidate that targets CD123, an antigen found certain leukemic cells in acute myeloid leukemia &#40;AML&#41; as well as leukemic and other cancer cells in blastic plasmacytoid dendritic cell neoplasm &#40;BPDCN&#41;.</li></ul><div class=\"tiny-share-widget\" data-id=\"3240912\" data-linked=\"Cellectis gets green light to start clinical trials in U.S. with UCART123; shares ahead 9% after hours\" data-tweet=\"$CLLS - Cellectis gets green light to start clinical trials in U.S. with UCART123; shares ahead 9% after hours https://seekingalpha.com/news/3240912-cellectis-gets-green-light-to-start-clinical-trials-in-u-s-ucart123-shares-ahead-9-after?source=tweet\" data-url=\"https://seekingalpha.com/news/3240912-cellectis-gets-green-light-to-start-clinical-trials-in-u-s-ucart123-shares-ahead-9-after\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240907\" data-ts=\"1486417216\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AM\" target=\"_blank\">AM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240907-antero-midstream-to-launch-5m-share-offering-forms-jv-mplx\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Antero Midstream to launch 5M-share offering, forms JV with MPLX</a></h4><ul><li>Antero Midstream Partners (NYSE:<a href='https://seekingalpha.com/symbol/AM' title='Antero Midstream Partners'>AM</a>) <font color='red'>-3.3%</font>&nbsp;AH after commencing a <a href=\"https://seekingalpha.com/pr/16734027-antero-midstream-announces-public-offering-common-units\" target=\"_blank\">public offering</a> of 5M common units, with an underwriters option to purchase up to an additional 750K units.</li><li>AM says it plans to use the proceeds for general corporate purposes, including repayment of part of the outstanding borrowings  under its revolving credit facility.</li><li>AM also says it is <a href=\"https://seekingalpha.com/pr/16733980-antero-midstream-announces-strategic-processing-fractionation-joint-venture-increased\" target=\"_blank\">forming a 50-50 joint venture</a> with <a href='https://seekingalpha.com/symbol/MPLX' title='MPLX LP'>MPLX</a> subsidiary MarkWest Energy to develop processing and fractionation  assets in the Marcellus Shale in West Virginia, in which it expects to invest up to $800M through 2020.</li><li>AM says the expansion opportunity allows it to target peer-leading  compound annual distribution growth of 28%-30% through 2020, while maintaining a strong balance sheet and increasing  its distributable cash flow coverage to more than 1.25x during the period.</li></ul><div class=\"tiny-share-widget\" data-id=\"3240907\" data-linked=\"Antero Midstream to launch 5M-share offering, forms JV with MPLX\" data-tweet=\"$AM $AM $MPLX - Antero Midstream to launch 5M-share offering, forms JV with MPLX https://seekingalpha.com/news/3240907-antero-midstream-to-launch-5m-share-offering-forms-jv-mplx?source=tweet\" data-url=\"https://seekingalpha.com/news/3240907-antero-midstream-to-launch-5m-share-offering-forms-jv-mplx\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:40 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240899\" data-ts=\"1486416631\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARCT\" target=\"_blank\">ARCT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240899-alcobra-says-fda-pre-ind-adair-meeting-productive-shares-ahead-6-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alcobra says FDA pre-IND ADAIR meeting &quot;productive,&quot; shares ahead 6% after hours</a></h4><ul><li>Nano cap Alcobra (ADHD) perks up&nbsp;<font color='green'>6%</font>&nbsp;after hours on increased volume on the heels of its <a href=\"https://seekingalpha.com/pr/16733981-alcobra-reports-productive-fda-meeting-new-lead-product-candidate-adhd\" target=\"_blank\">announcement </a>of a productive pre-IND meeting with the FDA regarding ADAIR (Abuse-Deterrent Amphetamine Immediate-Release), its candidate to treat attention deficit hyperactivity disorder &#40;ADHD&#41;.</li><li>The company says the agency provided guidance on the necessary steps for an NDA submission, expected to happen next year.</li><li>The company will host a conference call tomorrow, February 7, at 8:30 am ET to discuss its plans.</li></ul><div class=\"tiny-share-widget\" data-id=\"3240899\" data-linked=\"Alcobra says FDA pre-IND ADAIR meeting &quot;productive,&quot; shares ahead 6% after hours\" data-tweet=\"$ARCT - Alcobra says FDA pre-IND ADAIR meeting &quot;productive,&quot; shares ahead 6% after hours https://seekingalpha.com/news/3240899-alcobra-says-fda-pre-ind-adair-meeting-productive-shares-ahead-6-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3240899-alcobra-says-fda-pre-ind-adair-meeting-productive-shares-ahead-6-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240881\" data-ts=\"1486415741\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOX\" target=\"_blank\">FOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240881-fox-shares-turn-down-2_5-after-mixed-second-quarter-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fox shares turn down 2.5% after mixed second quarter results</a></h4><ul>   <li>Twenty-First Century Fox (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a>) A shares have turned down after hours, <font color='red'>-2.5%</font>, as the company logged a <a href=\"https://seekingalpha.com/news/3240868-twenty-first-century-fox-beats-0_04-misses-revenue\" target=\"_blank\">beat on profits</a> with strong results in cable and sports, though revenues missed slightly.</li>    <li>Income from continuing operations grew by more than 27%, to $857M. Revenues grew 4% on strength from cable and TV, with a drag from the film studio.</li>    <li>Total segment OIBDA was up 15% to $1.99B, above consensus for $1.86B.</li>    <li>\"Our record-breaking post-season baseball run underscores the immense value of our sports programming, as well as the broader competitive advantage we have built through our other leadership positions in entertainment and news,\" says a statement from Rupert and Lachlan Murdoch.</li>    <li>Revenue by segment: Cable Network Programming, $3.97B (up 7.1%); Television, $1.92B (up 11.8%); Filmed Entertainment, $2.27B (down 3.9%); Other, -$472M.</li>    <li><a href=\"http://www.21cf.com\" target=\"_blank\">Conference call</a> to come at 4:30 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/16733994-21st-century-fox-reports-second-quarter-income-continuing-operations-attributable\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3240881\" data-linked=\"Fox shares turn down 2.5% after mixed second quarter results\" data-tweet=\"$FOX $FOX $FOXA - Fox shares turn down 2.5% after mixed second quarter results https://seekingalpha.com/news/3240881-fox-shares-turn-down-2_5-after-mixed-second-quarter-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3240881-fox-shares-turn-down-2_5-after-mixed-second-quarter-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240855\" data-ts=\"1486414823\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WPP\" target=\"_blank\">WPP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240855-comscore-now-down-28_9-oppenheimer-pulls-buy-rating\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ComScore now down 28.9%; Oppenheimer pulls Buy rating</a></h4><ul>     <li>ComScore (<a href='https://seekingalpha.com/symbol/SCOR' title='comScore, Inc.'>SCOR</a> <font color='red'>-28.9%</font>) -- on the skids today after saying it would <a href=\"https://seekingalpha.com/news/3240775-set-miss-new-compliance-deadline-comscore-tumbles-21_9-percent\" target=\"_blank\">miss yet another compliance deadline</a> tied to an ongoing restatement of its financials -- has had its Buy rating pulled by Oppenheimer.</li>     <li>The news means likely delisting of comScore from Nasdaq, which will call for selling by index funds and mutual funds.</li>     <li>And while Oppenheimer says checks indicate \"business as usual,\" it expects that shareholder WPP (WPPGY) will push for a company sale late this year. It's gone from Outperform to \"Not Rated\" and pulled its $35 price target (shares have tumbled from $30.74 to $23.06 today and still falling into the close).</li>     <li>Who could buy comScore? The firm thinks Adobe, Oracle and IBM are likely suitors, but \"we believe there is no rush ahead of completion of the re-audit. However, we believe comparable assets trade at 3-5x cash sales.\"</li>   <li><a href=\"https://seekingalpha.com/news/search?query=comscore%20accounting\" target=\"_blank\">Much more on comScore's accounting problems</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3240855\" data-linked=\"ComScore now down 28.9%; Oppenheimer pulls Buy rating\" data-tweet=\"$WPP $WPP $SCOR - ComScore now down 28.9%; Oppenheimer pulls Buy rating https://seekingalpha.com/news/3240855-comscore-now-down-28_9-oppenheimer-pulls-buy-rating?source=tweet\" data-url=\"https://seekingalpha.com/news/3240855-comscore-now-down-28_9-oppenheimer-pulls-buy-rating\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240851\" data-ts=\"1486414336\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALGN\" target=\"_blank\">ALGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240851-fda-clears-dentsply-sironas-clear-aligner-system-align-tech-eases-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA clears Dentsply Sirona&#39;s clear aligner system; Align Tech eases 2%</a></h4><ul><li>Align Technology (<a href='https://seekingalpha.com/symbol/ALGN' title='Align Technology, Inc.'>ALGN</a> <font color='red'>-2%</font>) slumps on average volume on the heels of FDA's clearance of Dentsply Sirona's (<a href='https://seekingalpha.com/symbol/XRAY' title='DENTSPLY SIRONA, Inc'>XRAY</a> <font color='green'>+0.1%</font>) clear aligner system today which follows clearance of 3M's version on January 27.</li><li>Baird says that Align should be able to deliver mid-teens revenue growth despite the competition.</li><li>Source: The Fly</li></ul><div class=\"tiny-share-widget\" data-id=\"3240851\" data-linked=\"FDA clears Dentsply Sirona&#39;s clear aligner system; Align Tech eases 2%\" data-tweet=\"$ALGN $ALGN $XRAY - FDA clears Dentsply Sirona&#39;s clear aligner system; Align Tech eases 2% https://seekingalpha.com/news/3240851-fda-clears-dentsply-sironas-clear-aligner-system-align-tech-eases-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3240851-fda-clears-dentsply-sironas-clear-aligner-system-align-tech-eases-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240848\" data-ts=\"1486413244\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABT\" target=\"_blank\">ABT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240848-abiomed-up-5-on-abbotts-travails-heartmate\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Abiomed up 5% on Abbott&#39;s travails with HeartMate</a></h4><ul><li>Abbott's (<a href='https://seekingalpha.com/symbol/ABT' title='Abbott Laboratories'>ABT</a> <font color='red'>-0.8%</font>) suspension of enrollment in its HeartMate Shield 2 study and halted commercial sales in Europe stokes buying in Abiomed (<a href='https://seekingalpha.com/symbol/ABMD' title='ABIOMED, Inc.'>ABMD</a> <font color='green'>+4.7%</font>), maker of Impella heart pumps. Abbott's difficulties create a rosier outlook for Abiomed, say analysts.</li><li>Leerink's Danielle Antaffy rates ABMD Outperform with a $140 (27% upside) price target citing a one-to-two-year extension of ABMD's monopoly as result of Abbott's problems. Impella's ramp in Japan, set to start mid-year, should boost sales.</li><li>Jefferies' Raj Denhoy rates ABMD Buy with a $135 (23% upside) price target. He says Abbott's delay removes a key overhang on ABMD's growth story.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3240848\" data-linked=\"Abiomed up 5% on Abbott&#39;s travails with HeartMate\" data-tweet=\"$ABT $ABT $ABMD - Abiomed up 5% on Abbott&#39;s travails with HeartMate https://seekingalpha.com/news/3240848-abiomed-up-5-on-abbotts-travails-heartmate?source=tweet\" data-url=\"https://seekingalpha.com/news/3240848-abiomed-up-5-on-abbotts-travails-heartmate\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240846\" data-ts=\"1486411954\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNC\" target=\"_blank\">GNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240846-big-bets-on-gnc-holdings-earnings-approach\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Big bets on GNC Holdings as earnings approach</a></h4><ul> <li>Options traders are making some big bets on GNC Holdings (<a href='https://seekingalpha.com/symbol/GNC' title='GNC Holdings, Inc.'>GNC</a> <font color='red'>-7.6%</font>) ahead of the company's Q4 earnings report due out later this month.</li> <li>Bloomberg reports a block trade of 9.3K Feb $10 puts swapped hands at $1.65 along with 638K shares at $8.95.</li> <li>Shares of GNC are just off their 52-week low.</li> <li>SA contributor Courage &amp; Conviction posted an <a href=\"https://seekingalpha.com/article/4041958-discussion-hedge-fund-analyst-short-gnc\" target=\"_blank\">informative pro and con piece</a> on GNC last week based off a conversation with a hedge fund manager.</li> <li>Volume on GNC today is 50% more than normal activity.</li></ul><div class=\"tiny-share-widget\" data-id=\"3240846\" data-linked=\"Big bets on GNC Holdings as earnings approach\" data-tweet=\"$GNC - Big bets on GNC Holdings as earnings approach https://seekingalpha.com/news/3240846-big-bets-on-gnc-holdings-earnings-approach?source=tweet\" data-url=\"https://seekingalpha.com/news/3240846-big-bets-on-gnc-holdings-earnings-approach\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240843\" data-ts=\"1486411207\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240843-technology-top-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:&nbsp;</b><a href='https://seekingalpha.com/symbol/SEV' title='Sevcon, Inc.'>SEV</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/OESX' title='Orion Energy Systems, Inc'>OESX</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/ASUR' title='Asure Software, Inc.'>ASUR</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/QUIK' title='QuickLogic Corporation'>QUIK</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a> <font color='green'>+11%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/NIHD' title='NII Holdings, Inc.'>NIHD</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/XPLR' title='Xplore Technologies Corp.'>XPLR</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/MVIS' title='Microvision, Inc.'>MVIS</a> <font color='red'>-8%</font>. WPCS <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/CPSH' title='CPS Technologies Corp.'>CPSH</a> <font color='red'>-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3240843\" data-linked=\"Technology - Top Gainers / Losers as of 3:00 pm\" data-tweet=\"$SEV $OESX $ASUR - Technology - Top Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3240843-technology-top-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3240843-technology-top-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240842\" data-ts=\"1486411128\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OPTT\" target=\"_blank\">OPTT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240842-ocean-power-techplus-13-on-development-and-marketing-agreement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ocean Power Tech +13% on development and marketing agreement</a></h4><ul>     <li>Ocean Power Technologies (<a href='https://seekingalpha.com/symbol/OPTT' title='Ocean Power Technologies, Inc.'>OPTT</a> <font color='green'>+13.7%</font>) is higher after <a href=\"https://seekingalpha.com/pr/16733561-ocean-power-technologies-hai-technologies-announce-joint-application-development-marketing\" target=\"_blank\">announcing</a> a joint application development and marketing agreement with HAI Technologies and an initial focus on offshore oil and gas sub-sea chemical injection systems; financial terms of the pact are not disclosed.</li>     <li>Houston-based HAI Technologies specializes in products both for high power long wave acoustics and products for oil and gas subsea field development.</li><li>The companies say combining HAI's subsea chemical injection components with OPTT's PB3&nbsp;Power Buoy local  surface power system will reduce field development cost and potentially make impractical  fields practical.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3240842\" data-linked=\"Ocean Power Tech +13% on development and marketing agreement\" data-tweet=\"$OPTT - Ocean Power Tech +13% on development and marketing agreement https://seekingalpha.com/news/3240842-ocean-power-techplus-13-on-development-and-marketing-agreement?source=tweet\" data-url=\"https://seekingalpha.com/news/3240842-ocean-power-techplus-13-on-development-and-marketing-agreement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240838\" data-ts=\"1486410199\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PME\" target=\"_blank\">PME</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240838-pingtan-marine-enterprisesplus-13-positive-sentiment-extends\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pingtan Marine Enterprises +13% as positive sentiment extends</a></h4><ul> <li>Shares of Pingtan Marine Enterprises (NASDAQ:<a href='https://seekingalpha.com/symbol/PME' title='Pingtan Marine Enterprise Ltd.'>PME</a>) are <font color='green'>up 13.4%</font> on solid volume.</li> <li>The ocean fishing stock is now up 76% YTD.</li> <li>Earlier this month, Pingtan <a href=\"https://seekingalpha.com/pr/16708271-pingtan-marine-enterprise-provides-2017-first-quarter-eps-guidance-0_08-0_10\" target=\"_blank\">guided for</a> Q1 EPS of $0.08 to $0.10 and noted that market trends are working in its favor.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3240838\" data-linked=\"Pingtan Marine Enterprises +13% as positive sentiment extends\" data-tweet=\"$PME - Pingtan Marine Enterprises +13% as positive sentiment extends https://seekingalpha.com/news/3240838-pingtan-marine-enterprisesplus-13-positive-sentiment-extends?source=tweet\" data-url=\"https://seekingalpha.com/news/3240838-pingtan-marine-enterprisesplus-13-positive-sentiment-extends\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240833\" data-ts=\"1486409426\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240833-financials-top-5-gainers-losers-of-2-30-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 2:30 PM</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/LOAN' title='Manhattan Bridge Capital, Inc'>LOAN</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/FNBC' title='First NBC Bank Holding Company'>OTC:FNBC</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/NRT' title='North European Oil Royalty Trust'>NRT</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/LFC' title='China Life Insurance Company Limited'>LFC</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a> <font color='green'>+6%</font>.</li>     <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ZAIS' title='ZAIS Group Holdings'>ZAIS</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/LGIH' title='LGI Homes, Inc.'>LGIH</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/CFBK' title='Central Federal Corporation'>CFBK</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/YRD' title='Yirendai LTD.'>YRD</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/ENVA' title='Enova International, Inc.'>ENVA</a> <font color='red'>-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3240833\" data-linked=\"Financials - Top 5 Gainers / Losers as of 2:30 PM\" data-tweet=\"$LOAN $FNBC $NRT - Financials - Top 5 Gainers / Losers as of 2:30 PM https://seekingalpha.com/news/3240833-financials-top-5-gainers-losers-of-2-30-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3240833-financials-top-5-gainers-losers-of-2-30-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240831\" data-ts=\"1486407756\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240831-energy-materials-top-5-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/BCEI' title='Bonanza Creek Energy'>BCEI</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/SNMX' title='Senomyx, Inc.'>SNMX</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/COG' title='Cabot Oil & Gas Corporation'>COG</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/PVG' title='Pretium Resources Inc'>PVG</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/TANH' title='Tantech Holdings'>TANH</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ATW' title='Atwood Oceanics Inc.'>ATW</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/HOS' title='Hornbeck Offshore Services, Inc.'>HOS</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/ORIG' title='Ocean Rig UDW Inc.'>ORIG</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/CELP' title='Cypress Energy Partners, L.P.'>CELP</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/ESES' title='Eco-Stim Energy Solutions, Inc.'>ESES</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3240831\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm\" data-tweet=\"$BCEI $SNMX $COG - Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3240831-energy-materials-top-5-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3240831-energy-materials-top-5-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240824\" data-ts=\"1486404348\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYAD\" target=\"_blank\">CYAD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240824-celyad-to-explore-strategic-alternatives-for-c-cure-shares-ease-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Celyad to explore strategic alternatives for C-Cure; shares ease 2%</a></h4><ul><li>Belgium-based Celyad (<a href='https://seekingalpha.com/symbol/CYAD' title='Celyad'>CYAD</a> <font color='red'>-2.1%</font>) <a href=\"http://www.celyad.com/news/celyad-retains-piper-jaffray-co-to-explore-strategic-alternatives-relating-to-its-c-cure-cardiovascular-assets\" target=\"_blank\">announces </a>that it intends to evaluate strategic alternatives related to its C-Cure cardiovascular assets. Piper Jaffray is advising.</li><li><a href=\"http://www.celyad.com/our-science/cardiology-5\" target=\"_blank\">C-Cure</a> is an autologous cell therapy in development for the treatment of ischemic heart failure.</li></ul><div class=\"tiny-share-widget\" data-id=\"3240824\" data-linked=\"Celyad to explore strategic alternatives for C-Cure; shares ease 2%\" data-tweet=\"$CYAD - Celyad to explore strategic alternatives for C-Cure; shares ease 2% https://seekingalpha.com/news/3240824-celyad-to-explore-strategic-alternatives-for-c-cure-shares-ease-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3240824-celyad-to-explore-strategic-alternatives-for-c-cure-shares-ease-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240818\" data-ts=\"1486403580\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HIMX\" target=\"_blank\">HIMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240818-himax-technologies-downgraded-to-underweight-morgan-stanley-updated\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Himax Technologies downgraded to Underweight at Morgan Stanley [updated]</a></h4><ul><li>Having downgraded Himax Technologies <a href=\"https://seekingalpha.com/news/3221812-himax-technologies-downgraded-overweight-morgan-stanley\" target=\"_blank\">from Overweight to Equal Weight</a> in November 2016 (from which point shares have&nbsp;<font color='red'>declined 30%+</font>), Morgan Stanley&nbsp;<a href=\"http://www.streetinsider.com/Downgrades/Morgan+Stanley+Downgrades+Himax+Technologies+%28HIMX%29+to+Underweight/12501815.html\" target=\"_blank\">updates its rating</a>&nbsp;into negative territory.</li><li>Analyst Charlie Chan: \"We now see further threats to the dominance in micro display technology of LCoS (Liquid Crystal on Silicon). Vuzix, one of the leading vendors of AR smart glasses, won the CES Innovation Awards for its Blade 3000 and M3000, which incorporates DLP technology from Texas Instruments. DLP generally has the disadvantage of bigger form factor vs. LCoS, yet our read from Vuzix&rsquo;s press release suggests that this has been overcome. In addition, MicroVision, the solutions provider for laser MEMS micro display technology, became one of Vuzix's key suppliers starting from 2015.\"</li><li>Reduces Himax Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/HIMX' title='Himax Technologies, Inc.'>HIMX</a>) target from $6 to $4 (current price $5.11,&nbsp;<font color='red'>-2.48%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3240818\" data-linked=\"Himax Technologies downgraded to Underweight at Morgan Stanley [updated]\" data-tweet=\"$HIMX - Himax Technologies downgraded to Underweight at Morgan Stanley [updated] https://seekingalpha.com/news/3240818-himax-technologies-downgraded-to-underweight-morgan-stanley-updated?source=tweet\" data-url=\"https://seekingalpha.com/news/3240818-himax-technologies-downgraded-to-underweight-morgan-stanley-updated\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>124&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240815\" data-ts=\"1486403004\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240815-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:&nbsp;</b>GALE <font color='green'>+35%</font>. <a href='https://seekingalpha.com/symbol/PULM' title='Pulmatrix, Inc.'>PULM</a> <font color='green'>+32%</font>. <a href='https://seekingalpha.com/symbol/PSIX' title='Power Solutions International, Inc.'>OTCPK:PSIX</a> <font color='green'>+28%</font>. <a href='https://seekingalpha.com/symbol/SEV' title='Sevcon, Inc.'>SEV</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/NAKD' title='Naked Brand Group Limited'>NAKD</a> <font color='green'>+17%</font>. ARGS <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/PME' title='Pingtan Marine Enterprise Ltd.'>PME</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/HAS' title='Hasbro, Inc.'>HAS</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/OPTT' title='Ocean Power Technologies, Inc.'>OPTT</a> <font color='green'>+14%</font>.</li><li><b>Losers:&nbsp;</b><a href='https://seekingalpha.com/symbol/SCOR' title='comScore, Inc.'>SCOR</a> <font color='red'>-26%</font>. <a href='https://seekingalpha.com/symbol/PETX' title='Aratana Therapeutics'>PETX</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/LGIH' title='LGI Homes, Inc.'>LGIH</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/ATW' title='Atwood Oceanics Inc.'>ATW</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/ZAIS' title='ZAIS Group Holdings'>ZAIS</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/CELP' title='Cypress Energy Partners, L.P.'>CELP</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/MBRX' title='Moleculin Biotech, Inc.'>MBRX</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/XPLR' title='Xplore Technologies Corp.'>XPLR</a> <font color='red'>-11%</font>. AOI <font color='red'>-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3240815\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$SLS $PULM $PSIX - Midday Gainers / Losers https://seekingalpha.com/news/3240815-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3240815-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240812\" data-ts=\"1486401696\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/X\" target=\"_blank\">X</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240812-u-s-steel-now-buy-argus-following-november-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. Steel now a Buy at Argus following November downgrade</a></h4><ul>     <li>U.S. Steel (<a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a> <font color='green'>+3.5%</font>) is <a href=\"http://blogs.barrons.com/stockstowatchtoday/2017/02/06/this-analyst-just-upgraded-u-s-steel-less-than-3-months-after-cutting-it-heres-why/\" target=\"_blank\">upgraded to Buy</a> from Hold with a $39 price target at Argus - just three months after the firm issued a downgrade - now saying earnings estimates are rising following the company's bullish 2017 guidance.</li><li>Argus expects U.S. Steel to return to profitability this year with help from stronger pricing, continued cost reductions and tariffs on imported steel, and sees the company benefiting in 2017-18 from increased infrastructure spending under the Trump administration.</li><li>The firm also says the stock is trading at a discount to peers based on P/E, price/sales and price/cash flow.</li></ul><div class=\"tiny-share-widget\" data-id=\"3240812\" data-linked=\"U.S. Steel now a Buy at Argus following November downgrade\" data-tweet=\"$X - U.S. Steel now a Buy at Argus following November downgrade https://seekingalpha.com/news/3240812-u-s-steel-now-buy-argus-following-november-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3240812-u-s-steel-now-buy-argus-following-november-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240805\" data-ts=\"1486400454\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240805-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/NAKD' title='Naked Brand Group Limited'>NAKD</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/PME' title='Pingtan Marine Enterprise Ltd.'>PME</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/HAS' title='Hasbro, Inc.'>HAS</a> <font color='green'>+14%</font>.</li><li><b>Losers:</b> AOI <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/HNI' title='HNI Corporation'>HNI</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/KS' title='KapStone Paper and Packaging Corporation'>KS</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3240805\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$NAKD $PME $HAS - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3240805-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3240805-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240801\" data-ts=\"1486399859\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADES\" target=\"_blank\">ADES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240801-advanced-emissions-solutions-up-6-on-buy-rating\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Advanced Emissions Solutions up 6% on buy rating</a></h4><ul><li>Advanced Emissions Solutions (<a href='https://seekingalpha.com/symbol/ADES' title='Advanced Emissions Solutions, Inc.'>ADES</a> <font color='green'>+5.7%</font>) has received a buy rating from <br>analysts at Rodman &amp; Renshaw on coverage initiation.</li><li>They have set a price target of $18 implying 77% upside on&nbsp;Friday's close of $10.12.</li><li>The stock is up on thin trading volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3240801\" data-linked=\"Advanced Emissions Solutions up 6% on buy rating\" data-tweet=\"$ADES - Advanced Emissions Solutions up 6% on buy rating https://seekingalpha.com/news/3240801-advanced-emissions-solutions-up-6-on-buy-rating?source=tweet\" data-url=\"https://seekingalpha.com/news/3240801-advanced-emissions-solutions-up-6-on-buy-rating\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240799\" data-ts=\"1486398841\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PSIX\" target=\"_blank\">PSIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240799-power-solutions-downgraded-wunderlich-amid-too-much-uncertainty\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Power Solutions downgraded at Wunderlich amid too much uncertainty</a></h4><ul><li>Power Solutions International (<a href='https://seekingalpha.com/symbol/PSIX' title='Power Solutions International, Inc.'>OTCPK:PSIX</a> <font color='green'>+30.9%</font>) is <a href=\"http://www.marketwatch.com/story/power-solutions-downgraded-as-resignation-of-accountant-cfo-leaves-too-much-uncertainty-2017-02-06\" target=\"_blank\">downgraded</a> to Hold from Buy at Wunderlich, citing uncertainty around PSIX's business prospects following <a href=\"https://seekingalpha.com/news/3240574-power-solutions-halted-accounting-firm-resigns-cfo-takes-leave-absence\" target=\"_blank\">Friday's disclosure</a> that its independent accountant notified the company in its resignation letter of material weaknesses in internal controls, plus the resignation of the CFO.</li><li>Wunderlich's Liam Burke says despite the long-term potential  of PSIX's alternative fuel products and contracts that could drive future revenue, he cannot remain bullish  on the stock after the company's disclosures.</li><li>Shares are bouncing today but are still down more than 50% since the Friday afternoon disclosure.</li></ul><div class=\"tiny-share-widget\" data-id=\"3240799\" data-linked=\"Power Solutions downgraded at Wunderlich amid too much uncertainty\" data-tweet=\"$PSIX - Power Solutions downgraded at Wunderlich amid too much uncertainty https://seekingalpha.com/news/3240799-power-solutions-downgraded-wunderlich-amid-too-much-uncertainty?source=tweet\" data-url=\"https://seekingalpha.com/news/3240799-power-solutions-downgraded-wunderlich-amid-too-much-uncertainty\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:34 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240796\" data-ts=\"1486398641\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALT\" target=\"_blank\">ALT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240796-pharmathene-ex-d-today-related-to-2_91-special-dividend-shares-up-43\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PharmAthene ex-d today related to $2.91 special dividend; shares up 43%</a></h4><ul><li>PharmAthene (PIP)&nbsp;heads north&nbsp;<font color='green'>43%</font>&nbsp;on more than a 12x surge in volume. Today is the ex-dividend date for its special $2.91 cash dividend related to the SIGA settlement. The dividend was paid on Friday, February 3.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3225594-pharmathene-declares-special-cash-dividend-2_91\" target=\"_blank\">PharmAthene declares special cash dividend of $2.91</a> (Nov. 17, 2016)</li></ul><div class=\"tiny-share-widget\" data-id=\"3240796\" data-linked=\"PharmAthene ex-d today related to $2.91 special dividend; shares up 43%\" data-tweet=\"$ALT - PharmAthene ex-d today related to $2.91 special dividend; shares up 43% https://seekingalpha.com/news/3240796-pharmathene-ex-d-today-related-to-2_91-special-dividend-shares-up-43?source=tweet\" data-url=\"https://seekingalpha.com/news/3240796-pharmathene-ex-d-today-related-to-2_91-special-dividend-shares-up-43\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>67&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240798\" data-ts=\"1486398580\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VSTO\" target=\"_blank\">VSTO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240798-vista-outdoor-slumps-to-52-week-low\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vista Outdoor slumps to 52-week low</a></h4><ul> <li>DA Davidson lowers Vista Outdoor (<a href='https://seekingalpha.com/symbol/VSTO' title='Vista Outdoor'>VSTO</a> <font color='red'>-2.1%</font>) to a Neutral rating from Buy and reduces its price target to $28 from $35.</li> <li>The firm says softening ammunitrition trends \"cloud\" the earnings outlook.</li> <li>Shares of Vista hit a 52-week low of $24.46 earlier.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3240798\" data-linked=\"Vista Outdoor slumps to 52-week low\" data-tweet=\"$VSTO - Vista Outdoor slumps to 52-week low https://seekingalpha.com/news/3240798-vista-outdoor-slumps-to-52-week-low?source=tweet\" data-url=\"https://seekingalpha.com/news/3240798-vista-outdoor-slumps-to-52-week-low\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240793\" data-ts=\"1486397674\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COG\" target=\"_blank\">COG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240793-cabot-oil-gasplus-11-atlantic-sunrise-pipeline-approval-sparks-upgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cabot Oil &amp; Gas +11% as Atlantic Sunrise pipeline approval sparks upgrades</a></h4><ul>     <li>Cabot Oil &amp;&nbsp;Gas (<a href='https://seekingalpha.com/symbol/COG' title='Cabot Oil & Gas Corporation'>COG</a> <font color='green'>+10.9%</font>) surges more than 10% after two firms, J.P. Morgan and Susquehanna, <a href=\"http://thefly.com/landingPageNews.php?id=2500341&amp;headline=COG;WPZ;WMB-Cabot-Oil--Gas-climbs-after-Williams-pipeline-approval-sparks-upgrades\" target=\"_blank\">upgrade shares</a> to their equivalent of Buy ratings in reaction to <a href=\"https://seekingalpha.com/news/3240613-williams-partners-wins-ferc-authorization-atlantic-sunrise-project\" target=\"_blank\">Friday's FERC approval</a> of Williams Cos.' Atlantic Sunrise pipeline project; COG has said it expects to sell ~1B cf/day of gas via the pipeline.</li>     <li>In lifting shares to Overweight from  Neutral with a $27 price target in the wake of FERC's approval, J.P. Morgan says COG should deliver \"years of top-tier growth and free cash flow generation,\" estimating that the company's gross production will now rise to 3.7B cf/day by year-end 2018 from 2B cf/day at the end of 2016, with the company generating $500M of free cash flow over the next  two years.</li>     <li>Susquehanna, which now rates shares as Positive with a $26 target, estimates COG could generate $650M of free cash flow over the next two years while delivering nearly 50% production growth between Q4 2016 and Q4 2018.</li></ul><div class=\"tiny-share-widget\" data-id=\"3240793\" data-linked=\"Cabot Oil &amp; Gas +11% as Atlantic Sunrise pipeline approval sparks upgrades\" data-tweet=\"$COG - Cabot Oil &amp; Gas +11% as Atlantic Sunrise pipeline approval sparks upgrades https://seekingalpha.com/news/3240793-cabot-oil-gasplus-11-atlantic-sunrise-pipeline-approval-sparks-upgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/3240793-cabot-oil-gasplus-11-atlantic-sunrise-pipeline-approval-sparks-upgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240787\" data-ts=\"1486396803\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240787-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> GALE <font color='green'>+48%</font>. <a href='https://seekingalpha.com/symbol/PULM' title='Pulmatrix, Inc.'>PULM</a> <font color='green'>+31%</font>. ARGS <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/ANAB' title='AnaptysBio'>ANAB</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/NYMX' title='Nymox Pharmaceutical Corporation'>NYMX</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> PIP <font color='red'>-83%</font>. <a href='https://seekingalpha.com/symbol/PETX' title='Aratana Therapeutics'>PETX</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/MBRX' title='Moleculin Biotech, Inc.'>MBRX</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/ROKA' title='Roka Bioscience'>ROKA</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/ORPN' title='Bio Blast Pharma'>ORPN</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3240787\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$SLS $PULM $ARGSQ - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3240787-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3240787-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240780\" data-ts=\"1486394879\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NWBO\" target=\"_blank\">NWBO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240780-fda-lifts-partial-hold-on-northwest-bios-late-stage-study-of-dcvax-in-brain-cancer-shares-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA lifts partial hold on Northwest Bio&#39;s late-stage study of DCVax in brain cancer; shares up 5%</a></h4><ul><li>Northwest Biotherapeutics (<a href='https://seekingalpha.com/symbol/NWBO' title='Northwest Biotherapeutics, Inc.'>OTCQB:NWBO</a> <font color='green'>+4.5%</font>) perks up on light volume in response to its <a href=\"http://www.prnewswire.com/news-releases/nw-bio-announces-lifting-of-clinical-hold-on-dcvax-l-phase-iii-trial-by-fda-progression-free-survival-events-reached-overall-survival-events-not-yet-reached-300402381.html\" target=\"_blank\">announcement </a>that the FDA has lifted the partial clinical hold on its <a href=\"https://clinicaltrials.gov/ct2/show/NCT00045968?term=DCVax&amp;phase=2&amp;rank=1\" target=\"_blank\">Phase 3 clinical trial</a> assessing DCVax-L for the treatment of glioblastoma multiforme &#40;GBM&#41;.</li><li>The company says the study has accumulated a sufficient number of events (248) for the progression-free survival &#40;PFS&#41; endpoint, but not yet for overall survival (233) (several more months anticipated). Data lock will happen after the OS event threshold is achieved.</li></ul><div class=\"tiny-share-widget\" data-id=\"3240780\" data-linked=\"FDA lifts partial hold on Northwest Bio&#39;s late-stage study of DCVax in brain cancer; shares up 5%\" data-tweet=\"$NWBO - FDA lifts partial hold on Northwest Bio&#39;s late-stage study of DCVax in brain cancer; shares up 5% https://seekingalpha.com/news/3240780-fda-lifts-partial-hold-on-northwest-bios-late-stage-study-of-dcvax-in-brain-cancer-shares-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3240780-fda-lifts-partial-hold-on-northwest-bios-late-stage-study-of-dcvax-in-brain-cancer-shares-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>79&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240775\" data-ts=\"1486393718\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCOR\" target=\"_blank\">SCOR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240775-set-to-miss-new-compliance-deadline-comscore-tumbles-21_9\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Set to miss new compliance deadline, comScore tumbles 21.9%</a></h4><ul>   <li>ComScore (NASDAQ:<a href='https://seekingalpha.com/symbol/SCOR' title='comScore, Inc.'>SCOR</a>) has taken a dive, <font color='red'>-21.9%</font>, after an update that it <a href=\"https://seekingalpha.com/pr/16733081-comscore-provides-update-nasdaq-listing\" target=\"_blank\">won't be able to meet a deadline</a> set by Nasdaq's Hearings Panel over regaining compliance with its reporting requirements.</li>    <li>The company, rocked by accounting probes and delayed financials over the past year, was facing Feb. 23 as its latest deadline, but has informed the Panel that it can't make it.</li>    <li>\"While comScore has made significant progress toward completing the restatement process, it has determined that the aforementioned deadline will not be met,\" the company says.</li>    <li>It's targeting summer 2017 to finish restatement and get current. In the meantime, Nasdaq may suspend the stock from trading and delist it. If that happens, comScore intends to get shares quoted on OTC markets.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3240775\" data-linked=\"Set to miss new compliance deadline, comScore tumbles 21.9%\" data-tweet=\"$SCOR - Set to miss new compliance deadline, comScore tumbles 21.9% https://seekingalpha.com/news/3240775-set-to-miss-new-compliance-deadline-comscore-tumbles-21_9?source=tweet\" data-url=\"https://seekingalpha.com/news/3240775-set-to-miss-new-compliance-deadline-comscore-tumbles-21_9\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240773\" data-ts=\"1486393539\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FAST\" target=\"_blank\">FAST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240773-fastenal-reports-figures-for-january\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fastenal reports figures for January</a></h4><ul><li>Net sales up 9% to $336M; Daily sales growth of 3.8%; Daily sales growth of 2.6% in stores more than 10 years old, 3.2% in stores more than 5 years old and 2.9% in stores more than 2 years old.</li><li>Fastenal's (<a href='https://seekingalpha.com/symbol/FAST' title='Fastenal Company'>FAST</a> <font color='green'>+4%</font>) total store count totaled 2,505 with two stores opened YTD.</li><li>Source: <a href=\"http://thefly.com/landingPageNews.php?id=2500034&amp;headline=FAST-Fastenal-reports-January-net-sales-up--to-M\" target=\"_blank\">TheFly</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3240773\" data-linked=\"Fastenal reports figures for January\" data-tweet=\"$FAST - Fastenal reports figures for January https://seekingalpha.com/news/3240773-fastenal-reports-figures-for-january?source=tweet\" data-url=\"https://seekingalpha.com/news/3240773-fastenal-reports-figures-for-january\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240765\" data-ts=\"1486392470\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VSTO\" target=\"_blank\">VSTO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240765-vista-outdoor-on-move\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vista Outdoor on the move</a></h4><ul><li>Vista Outdoor (NYSE:<a href='https://seekingalpha.com/symbol/VSTO' title='Vista Outdoor'>VSTO</a>) <font color='red'>sinks 5.2%</font> in early trade following some analyst coverage.</li><li>DA Davidson <a href=\"http://www.streetinsider.com/Analyst+Comments/DA+Davidson+Downgrades+Vista+Outdoor+to+Neutral/12500182.html\" target=\"_blank\">downgraded</a> the stock to Neutral from Buy, citing weakening ammunition trends, and lowered its price target to $28 from $35.</li><li>Separately, KeyBanc <a href=\"http://www.streetinsider.com/Analyst+Comments/Vista+Outdoor+PT+Lowered+to+$31+at+KeyBanc/12500265.html\" target=\"_blank\">cut</a> its PT on shares to $31 from $39, saying channel checks show that retail demand for firearms and ammo came under increased pressure last month.</li></ul><div class=\"tiny-share-widget\" data-id=\"3240765\" data-linked=\"Vista Outdoor on the move\" data-tweet=\"$VSTO - Vista Outdoor on the move https://seekingalpha.com/news/3240765-vista-outdoor-on-move?source=tweet\" data-url=\"https://seekingalpha.com/news/3240765-vista-outdoor-on-move\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240758\" data-ts=\"1486392089\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSN\" target=\"_blank\">TSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240758-on-tyson-foods-fq1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Tyson Foods&#39; FQ1</a></h4><ul>     <li>Tyson Foods (<a href='https://seekingalpha.com/symbol/TSN' title='Tyson Foods Inc.'>TSN</a> <font color='red'>-2.5%</font>)&nbsp;reports total sales volume rose 1.6% in <a href=\"https://seekingalpha.com/pr/16733198-tyson-foods-best-start-company-history\" target=\"_blank\">FQ1</a>.</li>     <li>Segment Sales: Chicken: $2.71B (+2.7%); Beef: $3.53B (-2.4%); Pork: $1.25B (+3.2%); Prepared Foods: $1.9B (-0.1%); Other: $90M (-9.1%).</li>     <li>Segment Volume change: Chicken: +1.3%; Beef: +4.5%; Pork: +4.3%; Prepared Foods: +2.9%; Other: -6.7%.</li>     <li>Segment Average Price change: Chicken: +1.4%; Beef: -6.6%; Pork: -1%; Prepared Foods: -2.9%; Other: -2.7%.</li>     <li>Gross margin rate expanded 310 bps to 16.2%.</li>     <li>SG&amp;A expense rate grew 110 bps to 5.5%.</li>     <li>Operating margin rate increased 220 bps to 10.7%.</li>     <li>The company expects overall domestic protein production to increase ~2% to 3% Y/Y in FY2017.</li>     <li><b>FY2017 Guidance</b>: Sales: flat Y/Y; Chicken&nbsp;operating margin: upper end of normalized range of 9% to 11%; Beef operating margin: ~5%;&nbsp;Pork operating&nbsp;margin:&nbsp;~ 12%; Prepared Foods&nbsp;operating margin:&nbsp;down Y/Y;&nbsp;Other operating loss: ~$70M;&nbsp;Adjusted EPS: $4.90 - $5.05; Capital expenditure:&nbsp;~1B; Net interest&nbsp;expense: ~$230M; Liquidity: in range of $1B.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3240758\" data-linked=\"More on Tyson Foods&#39; FQ1\" data-tweet=\"$TSN - More on Tyson Foods&#39; FQ1 https://seekingalpha.com/news/3240758-on-tyson-foods-fq1?source=tweet\" data-url=\"https://seekingalpha.com/news/3240758-on-tyson-foods-fq1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240759\" data-ts=\"1486392089\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HAS\" target=\"_blank\">HAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240759-hasbro-runs-to-all-time-high-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hasbro runs to all-time high after earnings</a></h4><ul> <li>Hasbro (<a href='https://seekingalpha.com/symbol/HAS' title='Hasbro, Inc.'>HAS</a> <font color='red'>N/A</font>) pops to an all-time high after <a href=\"https://seekingalpha.com/pr/16733105-hasbro-reports-first-5-billion-revenue-year-growth-revenue-operating-profit-net-earnings-full\" target=\"_blank\">Q4</a> earnings dazzle on broad-based strength.</li> <li>The company topped most estimates in the boys and girls categories for the quarter.</li> <li>Management also points to the gaming business after it generated 11% revenue growth to $519M, calling it a \"competitive differentiator\" in the toy industry.</li> <li>Shares of Mattel (<a href='https://seekingalpha.com/symbol/MAT' title='Mattel, Inc.'>MAT</a> <font color='red'>N/A</font>) are also on the move after the solid numbers from its peer.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3240666-hasbro-beats-0_37-beats-revenue\" target=\"_blank\">Hasbro beats by $0.37, beats on revenue</a> (Feb. 6)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3240698-hasbro-positive-post-q4-results\" target=\"_blank\">Hasbro positive post Q4 results</a> (Feb. 6)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3240759\" data-linked=\"Hasbro runs to all-time high after earnings\" data-tweet=\"$HAS $HAS $MAT - Hasbro runs to all-time high after earnings https://seekingalpha.com/news/3240759-hasbro-runs-to-all-time-high-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3240759-hasbro-runs-to-all-time-high-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240757\" data-ts=\"1486391814\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLUU\" target=\"_blank\">GLUU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240757-glu-mobileplus-2_1-roth-upgrades-on-bookings-positivity\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Glu Mobile +2.1% as Roth upgrades on bookings positivity</a></h4><ul>   <li>Glu Mobile (NASDAQ:<a href='https://seekingalpha.com/symbol/GLUU' title='Glu Mobile Inc.'>GLUU</a>) has opened <font color='green'>up 2.1%</font> after an upgrade from Roth Capital, to Buy, ahead of the company's Wednesday earnings report.</li>    <li>The firm thinks its bookings may come in above guidance (for $46M-$48M), and that Q1 bookings are tracking ahead of estimates as well.</li>    <li>In addition, the core portfolio (anchored by <i>Kim Kardashian: Hollywood)</i> has stabilized, which suggests some growth possibilities from newer, non-celebrity-focused games, says Darren Aftahi.</li>    <li>He's lifted his price target to $3.25 from $2.00, implying 31% upside from here.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3240757\" data-linked=\"Glu Mobile +2.1% as Roth upgrades on bookings positivity\" data-tweet=\"$GLUU - Glu Mobile +2.1% as Roth upgrades on bookings positivity https://seekingalpha.com/news/3240757-glu-mobileplus-2_1-roth-upgrades-on-bookings-positivity?source=tweet\" data-url=\"https://seekingalpha.com/news/3240757-glu-mobileplus-2_1-roth-upgrades-on-bookings-positivity\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240749\" data-ts=\"1486391049\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAL\" target=\"_blank\">AAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240749-american-airlines-group-shakes-off-negative-bernstein-call\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Airlines Group shakes off negative Bernstein call</a></h4><ul> <li>Bernstein upgrades American Airlines Group (NASDAQ:<a href='https://seekingalpha.com/symbol/AAL' title='American Airlines Group'>AAL</a>) to Market Perform from Underperform and gives its price target on the carrier a bump to $43.</li> <li>The firm pulls its negative stance on AAL after factoring in macro trends and American's recently-issued guidance for 2017.</li> <li>Shares of America are <font color='green'>up 1.20%</font> to $44.73 premarket vs. a 52-week trading range of $24.85 to $50.64.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3240749\" data-linked=\"American Airlines Group shakes off negative Bernstein call\" data-tweet=\"$AAL - American Airlines Group shakes off negative Bernstein call https://seekingalpha.com/news/3240749-american-airlines-group-shakes-off-negative-bernstein-call?source=tweet\" data-url=\"https://seekingalpha.com/news/3240749-american-airlines-group-shakes-off-negative-bernstein-call\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240747\" data-ts=\"1486390963\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLS\" target=\"_blank\">SLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240747-galenas-two-mid-stage-neuvax-studies-to-continue-planned-shares-ahead-82-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Galena&#39;s two mid-stage NeuVax studies to continue as planned; shares ahead 82% premarket</a></h4><ul><li>Nano cap Galena Biopharma (GALE) is up&nbsp;<font color='green'>82%</font>&nbsp;premarket on robust volume in response to its <a href=\"https://seekingalpha.com/pr/16733166-galena-biopharma-reports-positive-outcome-data-safety-monitoring-board-two-neuvax-nelipepimut\" target=\"_blank\">announcement </a>that its two Phase 2 studies assessing NeuVax, in combination with Roche's Herceptin (trastuzumab), to prevent the recurrence of breast cancer will continue as planned.</li><li>The independent Data Safety Monitoring Board &#40;DSMB&#41; reviewed the data and determined that there were no safety signals and neither study was found to be futile.</li><li>In the Phase 2b trial in breast cancer patients with low-to-intermediate HER2 expression, the DSMB backed a change in the timing for the interim efficacy analysis, moving it up to six months after the last patient is enrolled instead of 12 months. The DSMD expects to perform the analysis by year end.</li><li>The other Phase 2, in high-risk HER2 3+ patients, will continue unmodified.</li><li><a href=\"http://galenabiopharma.com/pipeline/neuvax/\" target=\"_blank\">NeuVax&nbsp;</a>is an HER2-directed immunotherapy being investigated for the prevention of breast cancer recurrence after standard-of-care treatment in the adjuvant setting.&nbsp;<a href=\"http://www.cancer.gov/cancertopics/types/breast/adjuvant-fact-sheet\" target=\"_blank\">Adjuvant therapy</a>&nbsp;is any treatment given after primary (first-line) therapy.</li></ul><div class=\"tiny-share-widget\" data-id=\"3240747\" data-linked=\"Galena&#39;s two mid-stage NeuVax studies to continue as planned; shares ahead 82% premarket\" data-tweet=\"$SLS - Galena&#39;s two mid-stage NeuVax studies to continue as planned; shares ahead 82% premarket https://seekingalpha.com/news/3240747-galenas-two-mid-stage-neuvax-studies-to-continue-planned-shares-ahead-82-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3240747-galenas-two-mid-stage-neuvax-studies-to-continue-planned-shares-ahead-82-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240745\" data-ts=\"1486390848\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RBS\" target=\"_blank\">RBS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240745-rbs-expected-to-unveil-new-cost-cuts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RBS expected to unveil new cost cuts</a></h4><ul><li>Royal Bank of Scotland (NYSE:<a href='https://seekingalpha.com/symbol/RBS' title='The Royal Bank of Scotland Group plc'>RBS</a>) is preparing to unveil new cost-cutting measures when the bank reports its expected ninth consecutive annual loss later this month, <a href=\"https://www.theguardian.com/business/2017/feb/05/rbs-boss-ross-mcewan-unveil-more-cuts-pay-worth-3m-2016\" target=\"_blank\"><i>The Guardian</i> reports</a>.</li><li>CEO Ross McEwan has already admitted he will miss his target to slash the bank's cost-income ratio by 2019 because of Brexit.</li><li>RBS <font color='red'>-2.4%</font> premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3240745\" data-linked=\"RBS expected to unveil new cost cuts\" data-tweet=\"$RBS - RBS expected to unveil new cost cuts https://seekingalpha.com/news/3240745-rbs-expected-to-unveil-new-cost-cuts?source=tweet\" data-url=\"https://seekingalpha.com/news/3240745-rbs-expected-to-unveil-new-cost-cuts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240744\" data-ts=\"1486390676\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APO\" target=\"_blank\">APO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240744-apollo-global-management-gains-after-baml-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apollo Global Management gains after BAML upgrade</a></h4><ul> <li>Shares of Apollo Global Management (NYSE:<a href='https://seekingalpha.com/symbol/APO' title='Apollo Global Management, LLC'>APO</a>) break higher in early trading after Bank of America Merrill Lynch ungrades to Buy from Neutral.</li> <li>BAML lifts its price target to $27 from $23 on its view that Apollo's fee-related earnings will improve and investors may see more distributions.</li> <li>APO <font color='green'>+1.90%</font> premarket to $22.55.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3240744\" data-linked=\"Apollo Global Management gains after BAML upgrade\" data-tweet=\"$APO - Apollo Global Management gains after BAML upgrade https://seekingalpha.com/news/3240744-apollo-global-management-gains-after-baml-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3240744-apollo-global-management-gains-after-baml-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240742\" data-ts=\"1486390404\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240742-premarket-gainers-losers-of-9-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers as of 9:10 am</a></h4><ul> <li><b>Gainers:</b> GALE <font color='green'>+91%</font>. <a href='https://seekingalpha.com/symbol/NAKD' title='Naked Brand Group Limited'>NAKD</a> <font color='green'>+29%</font>. <a href='https://seekingalpha.com/symbol/HAS' title='Hasbro, Inc.'>HAS</a> <font color='green'>+12%</font>. CERU <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/PSIX' title='Power Solutions International, Inc.'>OTCPK:PSIX</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/PULM' title='Pulmatrix, Inc.'>PULM</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/COG' title='Cabot Oil & Gas Corporation'>COG</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/PERI' title='Perion Network Ltd.'>PERI</a> <font color='green'>+5%</font>.</li> <li><b>Losers:</b> PIP <font color='red'>-84%</font>. <a href='https://seekingalpha.com/symbol/PETX' title='Aratana Therapeutics'>PETX</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/DRD' title='DRDGOLD Limited'>DRD</a> <font color='red'>-7%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3240742\" data-linked=\"Premarket Gainers / Losers as of 9:10 am\" data-tweet=\"$SLS $NAKD $HAS - Premarket Gainers / Losers as of 9:10 am https://seekingalpha.com/news/3240742-premarket-gainers-losers-of-9-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3240742-premarket-gainers-losers-of-9-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240740\" data-ts=\"1486390344\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TIF\" target=\"_blank\">TIF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240740-investors-scramble-after-ceo-exit-tiffany\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Investors scramble after CEO exit at Tiffany</a></h4><ul> <li>Shares of Tiffany (NYSE:<a href='https://seekingalpha.com/symbol/TIF' title='Tiffany & Co.'>TIF</a>) are down sharply after the company announces the exit of CEO Frederic Cumenal.</li> <li>Mizuho <a href=\"https://www.marketbeat.com/stocks/NYSE/TIF/\" target=\"_blank\">downgrades</a> the retailer to Neutral from Buy and takes its price target down to $74 from $90.</li> <li>Analyst Bety Chen thinks consensus estimates on Tiffany are too high amid the near-term headwinds in Asia-Pacific and Europe.</li> <li><a href=\"https://seekingalpha.com/filing/3386208\" target=\"_blank\">SEC Form 8-K</a></li> <li>TIF <font color='red'>-3.06%</font> premarket to $78.01 vs. a 52-week trading range of $56.99 to $85.44. Looking ahead, Tiffany is due to report earnings on March 17.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3240740\" data-linked=\"Investors scramble after CEO exit at Tiffany\" data-tweet=\"$TIF - Investors scramble after CEO exit at Tiffany https://seekingalpha.com/news/3240740-investors-scramble-after-ceo-exit-tiffany?source=tweet\" data-url=\"https://seekingalpha.com/news/3240740-investors-scramble-after-ceo-exit-tiffany\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240732\" data-ts=\"1486389359\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRUE\" target=\"_blank\">TRUE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240732-truecarplus-3_55-upgraded-to-outperform-rbc-capital-markets\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TrueCar +3.55%; upgraded to Outperform at RBC Capital Markets</a></h4><ul><li>From Sector Perform, <a href=\"http://www.streetinsider.com/Analyst+Comments/RBC+Capital+Upgrades+TrueCar+%28TRUE%29+to+Outperform/12499837.html\" target=\"_blank\">analyst Mark Mahaney</a> notes TrueCar's (NASDAQ:<a href='https://seekingalpha.com/symbol/TRUE' title='TrueCar, Inc'>TRUE</a>) recovery over the last nine months following &nbsp;an&nbsp;<font color='red'>80% decline</font>&nbsp;in share price from late 2014 to early 2016 (execution issues) and current pricing that remains at approximately 50% of peak levels.</li><li>Further cites management discussions held in Q4, firm's modified TAM analysis and evaluation of U.S. car sales markets.</li><li>Price target from $12 to $17 (pre-market $13.70).</li></ul><div class=\"tiny-share-widget\" data-id=\"3240732\" data-linked=\"TrueCar +3.55%; upgraded to Outperform at RBC Capital Markets\" data-tweet=\"$TRUE - TrueCar +3.55%; upgraded to Outperform at RBC Capital Markets https://seekingalpha.com/news/3240732-truecarplus-3_55-upgraded-to-outperform-rbc-capital-markets?source=tweet\" data-url=\"https://seekingalpha.com/news/3240732-truecarplus-3_55-upgraded-to-outperform-rbc-capital-markets\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240731\" data-ts=\"1486389117\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FDX\" target=\"_blank\">FDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240731-fedex-perks-up-after-raymond-james-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FedEx perks up after Raymond James upgrade</a></h4><ul> <li>FedEx (NYSE:<a href='https://seekingalpha.com/symbol/FDX' title='FedEx Corporation'>FDX</a>) is on the move in premarket trading after Raymond James <a href=\"http://www.cnbc.com/2017/02/06/early-movers-has-fdx-tsn-nwl-tif-dis-more.html\" target=\"_blank\">upgrades</a> to Outperform from Market Perform.</li> <li>The firm sees TNT accretion benefits picking up and thinks the company's ground margins are at a bottom.</li> <li>RJ sets a price target if $210 on the shipper.</li> <li>FDX <font color='green'>+0.50%</font> premarket to $189.15.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3240731\" data-linked=\"FedEx perks up after Raymond James upgrade\" data-tweet=\"$FDX - FedEx perks up after Raymond James upgrade https://seekingalpha.com/news/3240731-fedex-perks-up-after-raymond-james-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3240731-fedex-perks-up-after-raymond-james-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240724\" data-ts=\"1486388009\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PETX\" target=\"_blank\">PETX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240724-aratana-says-entyce-will-not-be-commercially-available-until-q4-shares-down-18-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aratana says ENTYCE will not be commercially available until Q4; shares down 18% premarket</a></h4><ul><li>in a regulatory filing, Aratana Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PETX' title='Aratana Therapeutics'>PETX</a>) <a href=\"https://seekingalpha.com/filing/3386253\" target=\"_blank\">reports </a>that ENTYCE (capromorelin oral solution), approved by the FDA's Center for Veterinary Medicine &#40;CVM&#41; in May 2016, will not be commercially available until late 2017 while it works through the regulatory requirements to transfer manufacturing to a new vendor. The company received a response from CVM on February 2 requesting additional information regarding the proposed transfer.</li><li>ENTYCE is a flavored oral liquid approved to treat dogs who have lost their desire to eat, a condition affecting 10M canines each year.</li><li>Shares are off&nbsp;<font color='red'>18%</font>&nbsp;premarket on increased volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3240724\" data-linked=\"Aratana says ENTYCE will not be commercially available until Q4; shares down 18% premarket\" data-tweet=\"$PETX - Aratana says ENTYCE will not be commercially available until Q4; shares down 18% premarket https://seekingalpha.com/news/3240724-aratana-says-entyce-will-not-be-commercially-available-until-q4-shares-down-18-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3240724-aratana-says-entyce-will-not-be-commercially-available-until-q4-shares-down-18-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>42&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240719\" data-ts=\"1486387851\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DAL\" target=\"_blank\">DAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240719-bernstein-sees-clear-skies-for-delta\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bernstein sees clear skies for Delta</a></h4><ul>     <li>Bernstein upgrades Delta Air Lines (NYSE:<a href='https://seekingalpha.com/symbol/DAL' title='Delta Air Lines, Inc.'>DAL</a>) to Outperform from Market Perform on its view revenue management strategies will pay off.</li>     <li>'While the conventional view seems to be that it can't get any better at DAL, we think the company has been a pioneer in revenue management and as this is all undiscovered country don&rsquo;t feel comfortable putting a cap on margin potential in the short term,\" writes analyst David Vernon.</li>     <li>The investment firm is also more comfortable on the macro environment for the airline sector and booking trends.</li>     <li>Shares of Delta are <font color='green'>up 1.44%</font> premarket to $48.50.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3240719\" data-linked=\"Bernstein sees clear skies for Delta\" data-tweet=\"$DAL - Bernstein sees clear skies for Delta https://seekingalpha.com/news/3240719-bernstein-sees-clear-skies-for-delta?source=tweet\" data-url=\"https://seekingalpha.com/news/3240719-bernstein-sees-clear-skies-for-delta\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240710\" data-ts=\"1486386316\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NWL\" target=\"_blank\">NWL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240710-newell-rubbermaid-lower-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Newell Rubbermaid lower post Q4 results</a></h4><ul>     <li>Newell Rubbermaid (NYSE:<a href='https://seekingalpha.com/symbol/NWL' title='Newell Brands Inc.'>NWL</a>) reports core sales growth of 2.5% in <a href=\"https://seekingalpha.com/pr/16733108-newell-brands-announces-strong-fourth-quarter-full-year-results\" target=\"_blank\">Q4</a>, driven by strong results from the Writing, Baby, Home Solutions and Outdoor Solutions businesses.</li>     <li>Segment revenue growth: Writing: $462.4M (-0.8%, Core sales: +4.3%); Home Solutions: $391M (-11.5%,&nbsp;Core sales: +5.7%); Tools: $198.1M (-4.6%,&nbsp;Core sales: -21.1%);&nbsp;Commercial Products:&nbsp;$208.9M (+1%,&nbsp;Core sales: +0.8%); Baby &amp; Parenting:&nbsp;$241.7M (+1.6%,&nbsp;Core sales: +3.6%);&nbsp;Branded Consumables: $1.1B;&nbsp;Consumer Solutions: $709.7M;&nbsp;Outdoor Solutions: $730.6M;&nbsp;Process Solutions: $88.9M.</li>     <li>Normalized gross margin fell 120 bps to 37.2%.</li>     <li>Normalized operating margin rate grew 260 bps to 16.3%.</li>     <li><b>FY2017 Guidance</b>: Net sales: $14.52B to $14.72B (+9.5% to +11%); Core sales: +2.5% to +4%; Normalized EPS: $2.95 to $3.15; Tax rate: 26% to 27%.</li>     <li>NWL&nbsp;<font color='red'>-2.99%</font>&nbsp;premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3240710\" data-linked=\"Newell Rubbermaid lower post Q4 results\" data-tweet=\"$NWL - Newell Rubbermaid lower post Q4 results https://seekingalpha.com/news/3240710-newell-rubbermaid-lower-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3240710-newell-rubbermaid-lower-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240702\" data-ts=\"1486385267\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMG\" target=\"_blank\">CMG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240702-chipotle-on-watch-after-negative-barrons-piece\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chipotle on watch after negative Barron&#39;s piece</a></h4><ul> <li>Shares of Chipotle (NYSE:<a href='https://seekingalpha.com/symbol/CMG' title='Chipotle Mexican Grill, Inc.'>CMG</a>) tilt lower in early trading after a weekend <a href=\"http://www.barrons.com/articles/chipotle-barrons-sees-more-trouble-ahead-1486220377\" target=\"_blank\">piece</a> in Barron's points to the risk of higher expenses at the chain.</li> <li>\"We see no reason to doubt that food safety at Chipotle is improving and that fans can eat there with confidence. We have reservations, however, about the safety of earnings forecasts and the share price,\" writes Jack Hough.</li> <li>A worst-case scenario of a 35% drop in share price is laid out.</li> <li>CMG <font color='red'>-1.22%</font> premarket to $399.15.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3240702\" data-linked=\"Chipotle on watch after negative Barron&#39;s piece\" data-tweet=\"$CMG - Chipotle on watch after negative Barron&#39;s piece https://seekingalpha.com/news/3240702-chipotle-on-watch-after-negative-barrons-piece?source=tweet\" data-url=\"https://seekingalpha.com/news/3240702-chipotle-on-watch-after-negative-barrons-piece\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240698\" data-ts=\"1486384819\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HAS\" target=\"_blank\">HAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240698-hasbro-positive-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hasbro positive post Q4 results</a></h4><ul>     <li>Hasbro (NASDAQ:<a href='https://seekingalpha.com/symbol/HAS' title='Hasbro, Inc.'>HAS</a>) reports revenue rose 12% in <a href=\"https://seekingalpha.com/pr/16733105-hasbro-reports-first-5-billion-revenue-year-growth-revenue-operating-profit-net-earnings-full\" target=\"_blank\">Q4</a> after excluding the foreign exchange impact.</li>     <li>U.S. and&nbsp;Canada revenue increased 10% to 757.52M.</li>     <li>International revenue +10% to $757.74M, led by 21% growth in Latin America.</li>     <li>Entertainment and Licensing revenue soar 36% to $114.68M.</li>     <li>Sales by product category: Boys: $552.3M (-5%); Games: $518.7M (+11%); Girls: $394.2M (+52%), Preschool: $164.8M (-4%).</li>     <li>Franchise brand revenue grew 2% to $685.61M and Partner brand revenue up 16% to $433.72M.</li>     <li>Hasbro gaming revenue up 23% to $356.92M and Emerging brands expanded 18% to $153.69M for the quarter.</li>     <li>Operating margin rate declined 200 bps to 15.7%.</li>     <li>HAS&nbsp;<font color='green'>+6.68%</font>&nbsp;premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3240698\" data-linked=\"Hasbro positive post Q4 results\" data-tweet=\"$HAS - Hasbro positive post Q4 results https://seekingalpha.com/news/3240698-hasbro-positive-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3240698-hasbro-positive-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240695\" data-ts=\"1486384332\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSN\" target=\"_blank\">TSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240695-tyson-foods-beats-0_33-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tyson Foods beats by $0.33, beats on revenue</a></h4><ul><li>Tyson Foods (NYSE:<a href='https://seekingalpha.com/symbol/TSN' title='Tyson Foods Inc.'>TSN</a>): FQ1 EPS of $1.59 <font color='green'>beats by $0.33</font>.</li><li>Revenue of $9.18B (+0.3% Y/Y) <font color='green'>beats by $130M</font>.</li><li>Shares <font color='green'>+2.66%</font> PM.</li><li><a href='https://seekingalpha.com/pr/16733198-tyson-foods-best-start-company-history'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3240695\" data-linked=\"Tyson Foods beats by $0.33, beats on revenue\" data-tweet=\"$TSN - Tyson Foods beats by $0.33, beats on revenue https://seekingalpha.com/news/3240695-tyson-foods-beats-0_33-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3240695-tyson-foods-beats-0_33-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3240666\" data-ts=\"1486380698\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HAS\" target=\"_blank\">HAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3240666-hasbro-beats-0_37-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hasbro beats by $0.37, beats on revenue</a></h4><ul><li>Hasbro (NASDAQ:<a href='https://seekingalpha.com/symbol/HAS' title='Hasbro, Inc.'>HAS</a>): Q4 EPS of $1.64 <font color='green'>beats by $0.37</font>.</li><li>Revenue of $1.63B (+10.9% Y/Y) <font color='green'>beats by $130M</font>.</li><li>Shares <font color='green'>+1.4%</font> PM.</li><li><a href='https://seekingalpha.com/pr/16733105-hasbro-reports-first-5-billion-revenue-year-growth-revenue-operating-profit-net-earnings-full'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3240666\" data-linked=\"Hasbro beats by $0.37, beats on revenue\" data-tweet=\"$HAS - Hasbro beats by $0.37, beats on revenue https://seekingalpha.com/news/3240666-hasbro-beats-0_37-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3240666-hasbro-beats-0_37-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":55,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}